← Clinical Evidence

SRC-e33a330e27c5 Stelmach GE 1989

Evidence source and scope

Force production characteristics in Parkinson's disease.

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1007/bf00253633

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Stelmach GE, Teasdale N, Phillips J, Worringham CJ. Force production characteristics in Parkinson's disease. Exp Brain Res. 1989;76(1):165–72. DOI 10.1007/bf00253633

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — strength

STR-32-01

Limitations: Only current scoped checks; archived captures not authenticated against live originals.

Parkinson’s disease strength

Parkinson’s disease strength component — Historical target-force task

The abstract confirms targets at 15/30/45/60% maximum, comparable amplitude dispersion, irregular within-trial force trajectories and delayed initiation.

Source locator: Primary abstract

Limitations: AI-assisted source comparison; no raw-data verification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide